NO20051879L - Anvendelse av proteintyrosinfosfataseinhibitorer til forhindring og/eller behandling av kreft - Google Patents

Anvendelse av proteintyrosinfosfataseinhibitorer til forhindring og/eller behandling av kreft

Info

Publication number
NO20051879L
NO20051879L NO20051879A NO20051879A NO20051879L NO 20051879 L NO20051879 L NO 20051879L NO 20051879 A NO20051879 A NO 20051879A NO 20051879 A NO20051879 A NO 20051879A NO 20051879 L NO20051879 L NO 20051879L
Authority
NO
Norway
Prior art keywords
cancer
prevention
treatment
protein tyrosine
tyrosine phosphatase
Prior art date
Application number
NO20051879A
Other languages
English (en)
Other versions
NO20051879D0 (no
Inventor
Rob Hooft Van Huijsduijnen
Sebastien Walchli
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20051879D0 publication Critical patent/NO20051879D0/no
Publication of NO20051879L publication Critical patent/NO20051879L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

2005 -04- 1 8 44 SAMMENDRAG Oppfinnelsen angår anvendelse av en tverrbinder av en proteintyrosinfosfatase (PTP), særlig Sap-l, til fremstilling av et legemiddel for behandling og/eller forhindring av kreft.
NO20051879A 2002-10-02 2005-04-18 Anvendelse av proteintyrosinfosfataseinhibitorer til forhindring og/eller behandling av kreft NO20051879L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02022227 2002-10-02
PCT/EP2003/050666 WO2004030697A1 (en) 2002-10-02 2003-09-29 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer

Publications (2)

Publication Number Publication Date
NO20051879D0 NO20051879D0 (no) 2005-04-18
NO20051879L true NO20051879L (no) 2005-04-18

Family

ID=32049975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051879A NO20051879L (no) 2002-10-02 2005-04-18 Anvendelse av proteintyrosinfosfataseinhibitorer til forhindring og/eller behandling av kreft

Country Status (7)

Country Link
US (1) US20060275299A1 (no)
EP (1) EP1545616A1 (no)
JP (1) JP2006510599A (no)
AU (1) AU2003299182A1 (no)
CA (1) CA2498829A1 (no)
NO (1) NO20051879L (no)
WO (1) WO2004030697A1 (no)

Also Published As

Publication number Publication date
NO20051879D0 (no) 2005-04-18
AU2003299182A1 (en) 2004-04-23
US20060275299A1 (en) 2006-12-07
JP2006510599A (ja) 2006-03-30
CA2498829A1 (en) 2004-04-15
WO2004030697A1 (en) 2004-04-15
EP1545616A1 (en) 2005-06-29

Similar Documents

Publication Publication Date Title
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
ATE408601T1 (de) Fredericamycin-derivate
EE200300475A (et) Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis
NO20034549L (no) Behandling av type 2 diabetes med inhibitorer av dipeptidyl peptidase IV
SE9800836D0 (sv) New Compounds
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
NO20060398L (no) Anvendelse av en kombinasjon av en epidermal vekstfaktor reseptor kinase inhibitor og cytotoksiske midler for behandling og hemming av kreft
ME00578A (en) Use of gastrointestinal lipase inhibitors
ATE400577T1 (de) Anellierte dihydropyrane
NO20031806D0 (no) Anvendelse av pericytt apoptosehemmere for behandling og/eller forhindringav diabetisk retinopati
ATE282607T1 (de) Tryptase-inhibitoren
ES2163735T3 (es) Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
DK0991424T3 (da) Farmaceutiske præparater omfattende en inhibitor for aldosereduktase og en inhibitor for ACE
TR200100637T2 (tr) Yeni doğal ürün türevleri
DK1355906T3 (da) 2H-1-benzopyranderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende dem
BR0209155A (pt) Tablete farmacêutico tendo um teor de api elevado
IS6317A (is) Efni og lyf til að koma í veg fyrir endaþarms- og/eða ristilskrabbamein
IS7200A (is) Notkun á írbesartan til framleiðslu á lækningalyfjum sem notuð eru til að koma í veg fyrir eða meðhöndla lungnaháþrýsting
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
NO20051879L (no) Anvendelse av proteintyrosinfosfataseinhibitorer til forhindring og/eller behandling av kreft
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application